These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7749769)

  • 1. Variation in the practice of dose reduction of chemotherapeutic agents after weight loss or amputation.
    O'Marcaigh AS; Betcher DL; Gilchrist GS
    J Pediatr Hematol Oncol; 1995 May; 17(2):172-5. PubMed ID: 7749769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose reduction of chemotherapeutic agents after weight loss.
    O'Marcaigh AS; Gilchrist GS
    Am J Clin Oncol; 1997 Apr; 20(2):193-5. PubMed ID: 9124199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body surface area estimation in children using weight alone: application in paediatric oncology.
    Sharkey I; Boddy AV; Wallace H; Mycroft J; Hollis R; Picton S;
    Br J Cancer; 2001 Jul; 85(1):23-8. PubMed ID: 11437397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan.
    Kouno T; Katsumata N; Mukai H; Ando M; Watanabe T
    Jpn J Clin Oncol; 2003 Jun; 33(6):309-13. PubMed ID: 12913086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional study comparing variation in body surface area and chemotherapy dosing in pediatric oncology using two different methods.
    Jastaniah W; Aseeri M
    J Oncol Pharm Pract; 2010 Sep; 16(3):189-93. PubMed ID: 19808711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factor practice patterns among pediatric oncologists: results of a 1998 Pediatric Oncology Group Survey. Economic Evaluation Working Group the Pediatric Oncology Group.
    Parsons SK; Mayer DK; Alexander SW; Xu R; Land V; Laver J
    J Pediatr Hematol Oncol; 2000; 22(3):227-41. PubMed ID: 10864054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of carboplatin dosing strategies in oncology practices.
    Blankenship P; Waddell JA
    J Am Pharm Assoc (2003); 2013; 53(4):420-2. PubMed ID: 23892816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are medical oncologists biased in their treatment of the large woman with breast cancer?
    Madarnas Y; Sawka CA; Franssen E; Bjarnason GA
    Breast Cancer Res Treat; 2001 Mar; 66(2):123-33. PubMed ID: 11437098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
    Griggs JJ; Mangu PB; Anderson H; Balaban EP; Dignam JJ; Hryniuk WM; Morrison VA; Pini TM; Runowicz CD; Rosner GL; Shayne M; Sparreboom A; Sucheston LE; Lyman GH;
    J Clin Oncol; 2012 May; 30(13):1553-61. PubMed ID: 22473167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body surface area as a determinant of pharmacokinetics and drug dosing.
    Sawyer M; Ratain MJ
    Invest New Drugs; 2001 May; 19(2):171-7. PubMed ID: 11392451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.
    Choy H; Shyr Y; Cmelak AJ; Mohr PJ; Johnson DH
    Cancer; 2000 Mar; 88(6):1336-46. PubMed ID: 10717614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimalism in oncology.
    The Lancet Oncology
    Lancet Oncol; 2018 May; 19(5):579. PubMed ID: 29726372
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
    Gurney H
    J Clin Oncol; 1996 Sep; 14(9):2590-611. PubMed ID: 8823340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of metronomic chemotherapy in oncology: results from a national Italian survey.
    Collovà E; Sebastiani F; De Matteis E; Generali D; Aurilio G; Boccardo F; Crispino S; Cruciani G
    Tumori; 2011; 97(4):454-8. PubMed ID: 21989433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of normal tissue damage induced by cancer chemotherapy.
    Vriesendorp HM; Vriesendorp R; Vriesendorp FJ
    Cancer Chemother Pharmacol; 1987; 19(4):273-6. PubMed ID: 3297374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
    Schwartz J; Toste B; Dizon DS
    Gynecol Oncol; 2009 Jul; 114(1):53-6. PubMed ID: 19359030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body surface area for adjustment of drug dose.
    Drug Ther Bull; 2010 Mar; 48(3):33-6. PubMed ID: 20200147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology.
    Bennett CL; Smith TJ; Weeks JC; Bredt AB; Feinglass J; Fetting JH; Hillner BE; Somerfield MR; Winn RJ
    J Clin Oncol; 1996 Sep; 14(9):2511-20. PubMed ID: 8823330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy dosing in overweight and obese patients with cancer.
    Lyman GH; Sparreboom A
    Nat Rev Clin Oncol; 2013 Aug; 10(8):451-9. PubMed ID: 23856744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underutilization of Palliative Care for Patients with Advanced Peripheral Arterial Disease.
    Kwong M; Curtis EE; Mell MW
    Ann Vasc Surg; 2021 Oct; 76():211-217. PubMed ID: 34403753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.